These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 17965479)

  • 1. F-19848 A, a novel inhibitor of hyaluronic acid binding to cellular receptor CD44.
    Hirota-Takahata Y; Harada H; Tanaka I; Nakata T; Nakajima M; Takahashi M
    J Antibiot (Tokyo); 2007 Oct; 60(10):633-9. PubMed ID: 17965479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-16438s, novel binding inhibitors of CD44 and hyaluronic acid. II. Producing organism, fermentation, isolation, physico-chemical properties and structural elucidation.
    Hirota-Takahata Y; Harada H; Tanaka I; Nakata T; Nakajima M; Takahashi M
    J Antibiot (Tokyo); 2006 Dec; 59(12):777-84. PubMed ID: 17323644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F-16438s, novel binding inhibitors of CD44 and hyaluronic acid. I. Establishment of an assay method and biological activity.
    Harada H; Nakata T; Hirota-Takahata Y; Tanaka I; Nakajima M; Takahashi M
    J Antibiot (Tokyo); 2006 Dec; 59(12):770-6. PubMed ID: 17323643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
    Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
    Eliaz RE; Szoka FC
    Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13.
    Levesque MC; Haynes BF
    J Immunol; 1997 Dec; 159(12):6184-94. PubMed ID: 9550421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extravillous trophoblast cell invasion is promoted by the CD44-hyaluronic acid interaction.
    Takahashi H; Takizawa T; Matsubara S; Ohkuchi A; Kuwata T; Usui R; Matsumoto H; Sato Y; Fujiwara H; Okamoto A; Suzuki M; Takizawa T
    Placenta; 2014 Mar; 35(3):163-70. PubMed ID: 24439029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-κB ligand through Rho kinase.
    Ariyoshi W; Okinaga T; Knudson CB; Knudson W; Nishihara T
    Osteoarthritis Cartilage; 2014 Jan; 22(1):111-20. PubMed ID: 24185105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
    Kim HR; Wheeler MA; Wilson CM; Iida J; Eng D; Simpson MA; McCarthy JB; Bullard KM
    Cancer Res; 2004 Jul; 64(13):4569-76. PubMed ID: 15231668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
    Liu D; Zhang D; Mori H; Sy MS
    Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding.
    Päll T; Gad A; Kasak L; Drews M; Strömblad S; Kogerman P
    Oncogene; 2004 Oct; 23(47):7874-81. PubMed ID: 15361838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
    Liu D; Liu T; Sy MS
    Cell Immunol; 1998 Dec; 190(2):132-40. PubMed ID: 9878114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
    Hathcock KS; Hirano H; Murakami S; Hodes RJ
    J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain.
    Liu D; Sy MS
    J Immunol; 1997 Sep; 159(6):2702-11. PubMed ID: 9300690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
    Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
    J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
    Liao HX; Lee DM; Levesque MC; Haynes BF
    J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44.
    Levesque MC; Haynes BF
    Cell Immunol; 1999 May; 193(2):209-18. PubMed ID: 10222064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.
    Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA
    J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.